Related Experiment Videos
Preliminary fluorimetric screening of fourteen palladium complexes as potential antitumor agents
1Department of Chemistry and Chemical Engineering, Hunan University, Changsha, PRC.
Abstract:
Making use of the fact that the combination of a drug substance with DNA may inhibit the duplication, synthesis and proliferation of DNA and the consistency of the in vivo and in vitro interactions, the authors worked out a preliminary screening method for testing complex agents as potential antitumor drugs using ethidium bromide as a fluorescence probe. In this report, the method was applied for in vitro testing fourteen synthesized palladium(II)/phenanthroline/amino acid/chloride complexes as potential non-platinum antitumor agents. The fluorimetric screening method was compared with methylene blue tube test and trypan blue dye exclusion assay. All three methods gave agreeable results. Among the complexes tested, [Pd(phen)(lys)]Cl, [Pd(phen)(arg)]Cl and [Pd(phen)(pro)]Cl showed antineoplastic ratios for animal tumor S-180 56%, 50% and 48%, respectively, in accordance with the order of their binding constants with DNA, 7.96 x 10(6), 4.52 x 10(6) and 1.0 x 10(6), respectively. The test results show that fluorimetric method is simple, cheap and rapid, suitable for preliminary screening of antitumor complexes.
Insights
Researchers developed a rapid fluorimetric screening method using ethidium bromide to identify potential antitumor drugs. This method effectively identified palladium complexes with significant antineoplastic activity against S-180 tumors.
Area of Science:
- Medicinal Chemistry
- Biophysics
- Pharmacology
Background:
- Drug-DNA interactions can inhibit DNA replication and proliferation.
- Developing novel non-platinum antitumor agents is crucial for cancer therapy.
- Ethidium bromide serves as a fluorescence probe for DNA interaction studies.
Purpose of the Study:
- To establish a preliminary screening method for potential antitumor agents.
- To evaluate fourteen synthesized palladium(II)/phenanthroline/amino acid/chloride complexes.
- To compare a novel fluorimetric method with existing assays.
Main Methods:
- Utilized ethidium bromide fluorescence to detect drug-DNA interactions.
- In vitro testing of fourteen palladium complexes as potential antitumor agents.
- Compared fluorimetric screening with methylene blue tube test and trypan blue dye exclusion assay.
Main Results:
- The fluorimetric method showed agreeable results compared to methylene blue and trypan blue assays.
- [Pd(phen)(lys)]Cl, [Pd(phen)(arg)]Cl, and [Pd(phen)(pro)]Cl exhibited significant antineoplastic ratios (56%, 50%, 48%) against S-180 tumors.
- Observed correlation between DNA binding constants and antineoplastic activity.
Conclusions:
- The fluorimetric screening method is simple, rapid, and cost-effective for preliminary evaluation of antitumor complexes.
- Palladium complexes show promise as non-platinum antitumor agents.
- Drug-DNA binding affinity is a key factor in antitumor efficacy.